Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WELLNESS PHARMACY, INC. et al v. AZAR et al
Case Number:
1:20-cv-03082
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
February 24, 2022
FDA Commits To Compounding Drug Rulemaking
The U.S. Food and Drug Administration has decided to undertake administrative rulemaking regarding a memorandum that had created new regulations to fully implement a decades-old rule governing pharmacy compounding.
-
September 21, 2021
Pharmacies Win Remand Of FDA's Compounded Drug Memo
A D.C. federal judge on Tuesday ordered the U.S. Food and Drug Administration to either perform an analysis of its memorandum that created new regulations to fully implement a decades-old rule governing pharmacy compounding, or certify that the memo won't greatly impact small businesses, like the pharmacies challenging the memo.
-
March 17, 2021
Pharmacies Rip FDA Bid To End Compound Drugs Reg Case
A group of pharmacies challenging the U.S. Food and Drug Administration's new regulations concerning compounded medication distribution told a D.C. federal court Wednesday that its lawsuit is ripe for judicial review, slamming the agency's claim that the case is premature.
-
March 04, 2021
FDA Seeks Win In Suit Over Compounded Drug Agreements
The federal government is gunning to end a group of pharmacies' suit accusing the U.S. Food and Drug Administration of unlawfully issuing new regulations last October concerning compounded drug distribution, telling a D.C. federal court their case is not ripe for judicial review.
-
October 28, 2020
Pharmacies Sue FDA Over Compounded Drug Agreements
A group of pharmacies has accused the U.S. Food and Drug Administration of exceeding its authority by developing new agreements with states that upend long-standing regulations on compounding pharmacies, a move the group says will limit interstate commerce and add burdensome reporting requirements.